Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Measurement and Spatial Differentiation of Farmers’ Livelihood Resilience Under the COVID-19 Epidemic Outbreak in Rural China
Xu Zhao, Hengxing Xiang, Feifei Zhao
Social Indicators Research (2023) Vol. 166, Iss. 2, pp. 239-267
Open Access | Times Cited: 19
The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one
Mina Kelleni
Inflammopharmacology (2023) Vol. 31, Iss. 6, pp. 3335-3338
Open Access | Times Cited: 9
COVID-19 mortality paradox (United States vs Africa): Mass vaccination vs early treatment
Mina Kelleni
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?
Mina Kelleni
Inflammopharmacology (2021) Vol. 30, Iss. 1, pp. 343-348
Open Access | Times Cited: 16
Real-Life Practice of Kelleni’s Protocol in Treatment and Post Exposure Prophylaxis of SARS CoV-2 Omicron HV.1 and JN.1 Subvariants
Mina Kelleni
(2024)
Open Access | Times Cited: 1
NSAIDs/Nitazoxanide/Azithromycin Immunomodulatory Protocol Used in Adult, Geriatric, Pediatric, Pregnant, and Immunocompromised COVID-19 Patients: A Real-World Experience
Mina Kelleni
Canadian Journal of Medicine (2021)
Closed Access | Times Cited: 10
Could the next “disease X” be a pandemic of virus-induced encephalitis? What should our first medical response be?
Mina Kelleni
Expert Review of Anti-infective Therapy (2024)
Open Access
Scope of computational biology and bioinformatics toward the discovery of potential therapeutic agents against viral diseases
Sinosh Skariyachan
Future Virology (2022) Vol. 17, Iss. 5, pp. 257-260
Closed Access | Times Cited: 3
Peg-interferon Lambda Single Dose Treatment for COVID-19: A Call to Avoid another Hydroxychloroquine Fiasco.
Mina Kelleni
(2023)
Open Access | Times Cited: 1
Kelleni’s Protocol including Nitazoxanide and NSAIDs to Manage Dengue Virus Disease: A Novel Potential Game-Changer.
Mina Kelleni
(2023)
Open Access | Times Cited: 1
Kelleni’s Protocol Including NSAIDs and Nitazoxanide to Early Manage Dengue Virus Disease: A Novel Potential Broad Spectrum Antiviral Protocol
Mina Kelleni
(2023)
Open Access | Times Cited: 1
Repurposing BCG Vaccine to Protect my Parents, Children, and my Family against COVID-19: A Real-life Experience.
Mina Kelleni
(2021)
Open Access | Times Cited: 2
NSAIDs/Nitazoxanide/Azithromycin Immunomodulatory COVID Protocol Might Inhibit SARS CoV-2 Replication Through Disruption of NF-κB Signaling
Mina Kelleni
(2021)
Open Access
Use of Non-steroidal Anti-inflammatory Drugs in Treatment of COVID-19: Safe, Safe, and …. Lifesaving?
Mina Kelleni
(2021)
Open Access
Page 1

Scroll to top